top of page

Innovations in Bayesian Clinical Trials Virtual Symposium: A New Hybrid Phase I-II-III Clinical Trial Paradigm

5/4/21, 11:00 AM
America/Pacific Time UTC -8:00 / -7:00


Following the recent success of our complimentary ‘Innovations in Bayesian Clinical Trials Virtual Symposium and Interactive Workshops’ we are excited to announce we have extended the series and added a host of new webinars and speakers to the program. Join us for part two of this innovative series, which will expose you to cutting edge topics from industry leaders in Bayesian statistics.


During this program we will cover a range of topics presented by Bayesian experts in academia, regulatory and industry. The speakers will discuss:

  • Adaptive design, platform studies, complex innovative designs using Bayesian modeling
  • Novel clinical trial design that combines dose-finding with mixture cure modeling
  • Leveraging external control data for a clinical trial with Time-to-Event Endpoint

Meet our distinguished speakers:

  • Peter Thall, Anise J. Sorrell Professor in the Department of Biostatistics at M.D. Anderson Cancer Center and an adjunct faculty member of the Rice University Statistics Department
  • Jay Kyle Wathen, Vice President, Scientific Strategy & Innovation
  • Rajat Mukherjee, Executive Research Principal, SC QS&DS
  • Satrajit Roychoudhury, PhD, Senior Director, Statistical Research and Data Science Centre, Pfizer
  • Marius Thomas, Senior Principal Biostatistician, Novartis
  • Pantelis Vlachos, Principal, Strategic Consulting, Cytel
  • Alyssa Biller, Solutions Consultant, Cytel
  • Tianjian Zhou, Assistant Professor in the Department of Statistics at Colorado State University
Previous registration necessary?


Simultaneous translation ?


Will it be recorded?

A New Hybrid Phase I-II-III Clinical Trial Paradigm




Peter Thall, Jay Kyle Wathen, Rajat Mukherjee, Satrajit Roychoudhury, Marius Thomas, Pantelis Vlachos, Alyssa Biller, Tianjian Zhou

Link to Event
bottom of page